Glenn Dubin

Insider Reports History

Location
New York, NY
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Glenn Dubin:

Company Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Director Common Stock 770,607 $6,241,917 $8.10 01 Apr 2024 By DF Investment Partners LLC
C4 Therapeutics, Inc. Director Common Stock 22,075 $178,808 $8.10 01 Apr 2024 Direct
C4 Therapeutics, Inc. Director Common Stock 20,000 $162,000 $8.10 01 Apr 2024 By G&E Dubin Family Foundation

Insider Reports Filed by Glenn Dubin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CCCC C4 Therapeutics, Inc. 01 Apr 2024 1 +$11,000 4 Director 02 Apr 2024, 16:34
CCCC C4 Therapeutics, Inc. 02 Jan 2024 1 +$10,999 4 Director 03 Jan 2024, 16:12
CCCC C4 Therapeutics, Inc. 02 Oct 2023 1 +$10,999 4 Director 03 Oct 2023, 16:27
CCCC C4 Therapeutics, Inc. 03 Jul 2023 1 +$11,000 4 Director 05 Jul 2023, 16:24
CCCC C4 Therapeutics, Inc. 15 Jun 2023 1 $0 4 Director 16 Jun 2023, 16:23
CCCC C4 Therapeutics, Inc. 03 Apr 2023 1 +$11,002 4 Director 04 Apr 2023, 16:20
CCCC C4 Therapeutics, Inc. 03 Jan 2023 1 +$11,006 4 Director 04 Jan 2023, 15:16
CCCC C4 Therapeutics, Inc. 03 Oct 2022 1 +$10,993 4 Director 04 Oct 2022, 18:06
CCCC C4 Therapeutics, Inc. 01 Jul 2022 1 +$11,017 4 Director 05 Jul 2022, 16:12
CCCC C4 Therapeutics, Inc. 22 Jun 2022 1 $0 4 Director 23 Jun 2022, 16:16
CCCC C4 Therapeutics, Inc. 04 Apr 2022 1 +$10,028 4 Director 05 Apr 2022, 16:27
CCCC C4 Therapeutics, Inc. 04 Jan 2022 1 +$6,284 4 Director 18 Jan 2022, 15:30
CCCC C4 Therapeutics, Inc. 04 Oct 2021 1 +$6,209 4 Director 05 Oct 2021, 16:55
CCCC C4 Therapeutics, Inc. 02 Jul 2021 1 +$6,236 4 Director 20 Aug 2021, 16:30